Apple Inc. (AAPL) was reiterated a ‘Hold’ by Jefferies analysts on Tuesday. The broker however, cut its price target on the stock to $130 from $135 citing iPhone demand uncertainty.
On Tuesday, Apple Inc. printed a higher than average trading volume with the issue trading 59 million shares, compared to the average volume of 46.87 million. The stock began trading this morning at $117.98 to currently trade 4.85% lower from the prior days close of $119.72. On an intraday basis it has gotten as low as $113.71 and as high as $118.18.
AAPL shares are currently priced at 13.18x this year’s forecasted earnings compared to the industry’s 14.94x earnings multiple. The company’s current year and next year EPS growth estimates stand at 41.60% and 7.10% compared to the industry growth rates of -5.00% and 12.30%, respectively. AAPL has a t-12 price/sales ratio of 3.04. EPS for the same period registers at $8.65.
AAPL’s shares have declined 2.45% in the last 4 weeks and 4.80% in the past three months. Over the past 5 trading sessions the stock has gained 1.54%. Shares of the $649.63 billion market cap company are up 9.84% this year.
Celldex Therapeutics, Inc. (CLDX) was reiterated as ‘Outperform’ with a $42 from $45 price target on Tuesday by Oppenheimer.
CLDX shares recently lost $4.42 to $16.93. In the past 52 weeks, shares of Hampton, New Jersey-based biopharmaceutical company have traded between a low of $12.11 and a high of $32.82.
Shares are up 48.16% year-over-year and 16.99% year-to-date.
Analysts at Credit Agricole downgraded Rackspace Hosting, Inc. (RAX) from ‘Outperform‘ to ‘Underperform‘ in a research report issued to clients on Tuesday.
On valuation measures, Rackspace Hosting Inc. stock it’s trading at a forward P/E multiple of 25.63x, and at a multiple of 35.53x this year’s estimated earnings. The t-12-month revenue at Rackspace is $1.85 billion. RAX ‘s ROE for the same period is 10.08%.
Shares of the $4.01 billion market cap company are up 4.48% year-over-year ; down 32.22% year-to-date.
Rackspace Hosting Inc., currently with a median Wall Street price target of $48 and a high target of $74, dropped $3.72 to $28.07 in recent trading.
Piper Jaffray reported on Tuesday that they have lowered their rating for YuMe, Inc. (YUME). The firm has downgraded YUME from ‘Overweight‘ to ‘Neutral‘ and lowered its price target to $4 from $8.
Shares have traded today between $3.29 and $3.95 with the price of the stock fluctuating between $3.29 to $6.38 over the last 52 weeks.
YuMe Inc. shares have a t-12 price/sales ratio of 0.85. EPS for the same period registers at ($0.29).
Shares of YUME have lost $1.24 to $3.36 in mid-day trading on Tuesday, giving it a market cap of roughly $112.50 million. The stock traded as high as $6.38 in Feb. 18, 2015.